{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T22:35:57Z","timestamp":1791412557953,"version":"4.3.3"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,10]]},"abstract":"<jats:sec>\n            <jats:title>OBJECTIVES:<\/jats:title>\n            <jats:p>To assess the effects of antibiotics delivered via the respiratory tract in preventing ventilator-associated pneumonia (VAP).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>DATA SOURCES:<\/jats:title>\n            <jats:p>We searched PubMed, Scopus, the Cochrane Library, and ClinicalTrials.gov for studies published in English up to October 25, 2023.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>STUDY SELECTION:<\/jats:title>\n            <jats:p>Adult patients with mechanical ventilation of over 48\u2009h and receiving inhaled or instilled antibiotics (with control group) to prevent VAP were included.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>DATA EXTRACTION:<\/jats:title>\n            <jats:p>Two independent groups screened studies, extracted the data, and assessed the risk of bias. The Grading of Recommendations Assessment, Development, and Evaluation approach was used to assess the certainty\/quality of the evidence. Results of a random-effects model were reported for overall and predefined subgroup meta-analyses. The analysis was primarily conducted on randomized controlled trials, and observational studies were used for sensitivity analyses.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>DATA SYNTHESIS:<\/jats:title>\n            <jats:p>Seven RCTs with 1445 patients were included, of which six involving 1283 patients used nebulizers to deliver antibiotics. No obvious risk of bias was found among the included RCTs for the primary outcome. Compared with control group, prophylactic antibiotics delivery via the respiratory tract significantly reduced the risk of VAP (risk ratio [RR], 0.69 [95% CI, 0.53\u20130.89]), particularly in subgroups where aminoglycosides (RR, 0.67 [0.47\u20130.97]) or nebulization (RR, 0.64 [0.49\u20130.83]) were used as opposed to other antibiotics (ceftazidime and colistin) or intratracheal instillation. No significant differences were observed in mortality, mechanical ventilation duration, ICU and hospital length of stay, duration of systemic antibiotics, need for tracheostomy, and adverse events between the two groups. Results were confirmed in sensitivity analyses.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSIONS:<\/jats:title>\n            <jats:p>In adult patients with mechanical ventilation for over 48\u2009h, prophylactic antibiotics delivered via the respiratory tract reduced the risk of VAP, particularly for those treated with nebulized aminoglycosides.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/ccm.0000000000006323","type":"journal-article","created":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T14:04:43Z","timestamp":1715263483000},"page":"1612-1623","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":17,"title":["Prophylactic Antibiotics Delivered Via the Respiratory Tract to Reduce Ventilator-Associated Pneumonia: A Systematic Review, Network Meta-Analysis, and Trial Sequential Analysis of Randomized Controlled Trials"],"prefix":"10.1097","volume":"52","author":[{"given":"Jie","family":"Li","sequence":"first","affiliation":[{"name":"Division of Respiratory Care, Department of Cardiopulmonary Sciences, Rush University, Chicago, IL."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Lyu","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Peking University People\u2019s Hospital, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Luo","sequence":"additional","affiliation":[{"name":"Respiratory Medicine Unit and Oxford NIHR Biomedical Research Centre, NDM Experimental Medicine, University of Oxford, Oxford, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fai A.","family":"Albuainain","sequence":"additional","affiliation":[{"name":"Department of Respiratory Care, College of Applied Medical Sciences, Imam Abdulrahman Bin Faisal University, Jubail, Saudi Arabia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar A.","family":"Alamoudi","sequence":"additional","affiliation":[{"name":"Division of Respiratory Care, Department of Cardiopulmonary Sciences, Rush University, Chicago, IL."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Violaine","family":"Rochette","sequence":"additional","affiliation":[{"name":"CHRU Tours, M\u00e9decine Intensive R\u00e9animation, CIC INSERM 1415, CRICS-TriggerSep F-CRIN research network, Tours, France."},{"name":"INSERM, Centre d\u2019\u00e9tude des pathologies respiratoires, U1100, Universit\u00e9 de Tours, Tours, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Ehrmann","sequence":"additional","affiliation":[{"name":"CHRU Tours, M\u00e9decine Intensive R\u00e9animation, CIC INSERM 1415, CRICS-TriggerSep F-CRIN research network, Tours, France."},{"name":"INSERM, Centre d\u2019\u00e9tude des pathologies respiratoires, U1100, Universit\u00e9 de Tours, Tours, France."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,5,9]]},"reference":[{"key":"R1-20250502","first-page":"CD008367","article-title":"Oral hygiene care for critically ill patients to prevent ventilator-associated pneumonia.","volume":"12","author":"Zhao","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"R2-20250502","doi-asserted-by":"crossref","first-page":"1700582","DOI":"10.1183\/13993003.00582-2017","article-title":"International ERS\/ESICM\/ESCMID\/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia. Guidelines for the management of hospital-acquired pneumonia (HAP)\/ventilator-associated pneumonia (VAP) of the European Respiratory Society (ERS), European Society of Intensive Care Medicine (ESICM), European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and Asociaci\u00f3n Latinoamericana del T\u00f3rax (ALAT).","volume":"50","author":"Torres","year":"2017","journal-title":"Eur Respir J"},{"key":"R3-20250502","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1378\/chest.122.6.2115","article-title":"Epidemiology and outcomes of ventilator-associated pneumonia in a large US database.","volume":"122","author":"Rello","year":"2002","journal-title":"Chest"},{"key":"R4-20250502","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S1473-3099(13)70081-1","article-title":"Attributable mortality of ventilator-associated pneumonia: A meta-analysis of individual patient data from randomised prevention studies.","volume":"13","author":"Melsen","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"R5-20250502","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1001\/jamainternmed.2013.9763","article-title":"Health care-associated infections: A meta-analysis of costs and financial impact on the US health care system.","volume":"173","author":"Zimlichman","year":"2013","journal-title":"JAMA Intern Med"},{"key":"R6-20250502","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jcrc.2017.09.019","article-title":"Effect of antibiotics administered via the respiratory tract in the prevention of ventilator-associated pneumonia: A systematic review and meta-analysis.","volume":"43","author":"P\u00f3voa","year":"2018","journal-title":"J Crit Care"},{"key":"R7-20250502","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1186\/s40001-023-01323-z","article-title":"Prophylactic antibiotics for preventing ventilator-associated pneumonia: A pairwise and Bayesian network meta-analysis.","volume":"28","author":"Zha","year":"2023","journal-title":"Eur J Med Res"},{"key":"R8-20250502","doi-asserted-by":"crossref","first-page":"R123","DOI":"10.1186\/cc5032","article-title":"Administration of antibiotics via the respiratory tract for the prevention of ICU-acquired pneumonia: A meta-analysis of comparative trials.","volume":"10","author":"Falagas","year":"2006","journal-title":"Crit Care"},{"key":"R9-20250502","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1172\/JCI107490","article-title":"Prevention of gram-negative bacillary pneumonia using aerosol polymyxin as prophylaxis. I. Effect on the colonization pattern of the upper respiratory tract of seriously ill patients.","volume":"52","author":"Greenfield","year":"1973","journal-title":"J Clin Invest"},{"key":"R10-20250502","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1378\/chest.65.6.650","article-title":"Endotracheally administered gentamicin for the prevention of infections of the respiratory tract in patients with tracheostomy: A double-blind study.","volume":"65","author":"Klastersky","year":"1974","journal-title":"Chest"},{"key":"R11-20250502","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1007\/BF01752973","article-title":"Systemic and endotracheal antibiotic prophylaxis of nosocomial pneumonia in ICU.","volume":"18","author":"Lode","year":"1992","journal-title":"Intensive Care Med"},{"key":"R12-20250502","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1172\/JCI107957","article-title":"Prevention of gram-negative bacillary pneumonia using polymyxin aerosol as prophylaxis. II. Effect on the incidence of pneumonia in seriously ill patients.","volume":"55","author":"Klick","year":"1975","journal-title":"J Clin Invest"},{"key":"R13-20250502","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/BF01704698","article-title":"Prevention of gram negative nosocomial bronchopneumonia by intratracheal colistin in critically ill patients. Histologic and bacteriologic study.","volume":"20","author":"Rouby","year":"1994","journal-title":"Intensive Care Med"},{"key":"R14-20250502","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1089\/sur.2006.042","article-title":"Aerosolized ceftazidime prophylaxis against ventilator-associated pneumonia in high-risk trauma patients: Results of a double-blind randomized study.","volume":"8","author":"Claridge","year":"2007","journal-title":"Surg Infect (Larchmt)"},{"key":"R15-20250502","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1183\/13993003.02235-2014","article-title":"Nebulised colistin for ventilator-associated pneumonia prevention.","volume":"46","author":"Karvouniaris","year":"2015","journal-title":"Eur Respir J"},{"issue":"Suppl 1","key":"R16-20250502","doi-asserted-by":"crossref","first-page":"P121","DOI":"10.1186\/cc14201","article-title":"Early preventive administration of inhaled tobramycin in severe polytrauma.","volume":"19","author":"Kuzovlev","year":"2015","journal-title":"Crit Care"},{"key":"R17-20250502","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1055\/s-2007-998870","article-title":"Prevention of pneumonia by endotracheal micronebulization of tobramycin.","volume":"28","author":"Rathgeber","year":"1993","journal-title":"Anasthesiol Intensivmed Notfallmed Schmerzther"},{"key":"R18-20250502","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1592\/phco.22.12.972.33596","article-title":"Aerosolized ceftazidime for prevention of ventilator-associated pneumonia and drug effects on the proinflammatory response in critically ill trauma patients.","volume":"22","author":"Wood","year":"2002","journal-title":"Pharmacotherapy"},{"key":"R19-20250502","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1056\/NEJMoa2310307","article-title":"Inhaled amikacin to prevent ventilator-associated pneumonia.","volume":"389","author":"Ehrmann","year":"2023","journal-title":"N Engl J Med"},{"key":"R20-20250502","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews.","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"R21-20250502","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: A revised tool for assessing risk of bias in randomised trials.","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"R22-20250502","article-title":"Cochrane handbook for systematic reviews of interventions Version 6.4, 2023.","author":"Higgins"},{"key":"R23-20250502","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1177\/0962280219889080","article-title":"Estimating the sample mean and standard deviation from commonly reported quantiles in meta-analysis.","volume":"29","author":"McGrath","year":"2020","journal-title":"Stat Methods Med Res"},{"key":"R24-20250502","first-page":"719","article-title":"Statistical aspects of the analysis of data from retrospective studies of disease.","volume":"22","author":"Mantel","year":"1959","journal-title":"J Natl Cancer Inst"},{"key":"R25-20250502","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1093\/biomet\/37.3-4.256","article-title":"The comparison of percentages in matched samples.","volume":"37","author":"Cochran","year":"1950","journal-title":"Biometrika"},{"key":"R26-20250502","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12874-017-0315-7","article-title":"Trial sequential analysis in systematic reviews with meta-analysis.","volume":"17","author":"Wetterslev","year":"2017","journal-title":"BMC Med Res Methodol"},{"key":"R27-20250502","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/jrsm.1058","article-title":"Network meta-analysis, electrical networks and graph theory.","volume":"3","author":"R\u00fccker","year":"2012","journal-title":"Res Synth Methods"},{"key":"R28-20250502","doi-asserted-by":"crossref","first-page":"e003111","DOI":"10.1136\/bmjopen-2013-003111","article-title":"Methods used to conduct and report Bayesian mixed treatment comparisons published in the medical literature: A systematic review.","volume":"3","author":"Sobieraj","year":"2013","journal-title":"BMJ Open"},{"key":"R29-20250502","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s13643-017-0473-z","article-title":"Approaches to interpreting and choosing the best treatments in network meta-analyses.","volume":"6","author":"Mbuagbaw","year":"2017","journal-title":"Syst Rev"},{"key":"R30-20250502","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables.","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"R31-20250502","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s13613-016-0169-x","article-title":"Aerosol delivery with two ventilation modes during mechanical ventilation: A randomized study.","volume":"6","author":"Dugernier","year":"2016","journal-title":"Ann Intensive Care"},{"key":"R32-20250502","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.idnow.2022.05.003","article-title":"Inhaled antibiotics in critical care: State of the art and future perspectives.","volume":"52","author":"Szychowiak","year":"2022","journal-title":"Infect Dis Now"},{"key":"R33-20250502","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1016\/S0140-6736(99)04149-5","article-title":"Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of reporting of meta-analyses.","volume":"354","author":"Moher","year":"1999","journal-title":"Lancet"}],"container-title":["Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CCM.0000000000006323","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T16:01:48Z","timestamp":1746201708000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CCM.0000000000006323"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,9]]},"references-count":33,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/ccm.0000000000006323","relation":{},"ISSN":["0090-3493","1530-0293"],"issn-type":[{"value":"0090-3493","type":"print"},{"value":"1530-0293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,9]]}}}